This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) rose 1.30% to $660.49 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.48% to 4,175.48 and the Dow Jones Industrial Average rising 0.20% to 33,128.79. The stock's rise snapped a two-day losing streak. Regeneron Pharmaceuticals Inc. closed $86.93 below its 52-week high ($747.42), which the company achieved on April 8th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.20% to $178.29, Novartis AG ADR (NOVN.EB) fell 0.19% to $87.48, and Amgen Inc. (AMGN) rose 0.55% to $232.19. Trading volume (538,564) remained 103,510 below its 50-day average volume of 642,074.
Data source: Dow Jones Market Data, FactSet. Data compiled May 3, 2022.
(END) Dow Jones Newswires
May 03, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.